Search results
Results From The WOW.Com Content Network
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
The Kingdom of Portugal [3] was a monarchy in the western Iberian Peninsula and the predecessor of the modern Portuguese Republic. Existing to various extents between 1139 and 1910, it was also known as the Kingdom of Portugal and the Algarves after 1415, and as the United Kingdom of Portugal, Brazil and the Algarves between 1815 and 1822.
[1] [4] [5] It contains olopatadine hydrochloride and mometasone furoate monohydrate. [1] [4] It is sprayed into the nose. [1] [4] Common side effects include an unpleasant taste . [1] It was approved for medical use in Australia in December 2019, [1] [6] and in the United States in January 2022. [4]
The United Kingdom of Portugal, Brazil and the Algarves was a pluricontinental monarchy formed by the elevation of the Portuguese colony named State of Brazil to the status of a kingdom and by the simultaneous union of that Kingdom of Brazil with the Kingdom of Portugal and the Kingdom of the Algarves, constituting a single state consisting of three kingdoms.
Mometasone furoate 0.1% (Elocon, ... Aristocort A ointment) Mometasone furoate 0.1% (Elocon cream, lotion) ... In the United Kingdom and New Zealand I is the ...
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
About 38% of the United Kingdom population has a university or college degree, which is the highest percentage in Europe, and among the highest percentage in the world. [413] The United Kingdom is home to many universities, including the University of Oxford and University of Cambridge which often achieve first place on global rankings. [414] [415]
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]